Welcome
Support Centre
11 February 2012 
Current Controlled Trials - Clinical Trials
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   news
Introduction
English introduction Introduction en français Deutsche einleitung
Introducción española Introduzione in italiano
 
Find trials
active registers
mental health register
archived registers
all registers
tips on searching
 
 
Information
about mRCT
mRCT FAQs

DISCLAIMER
The site should not be used to diagnose or treat a health problem. Please consult your doctor.
Terms & conditions

DUPLICATION
Your search result may contain a number of different records for the same trial. This occurs when the same trial is listed in more than one register.

[ ...Back to search results ] [ Print-friendly version ]
Rescue angioplasty versus conservative treatment or repeat thrombolysis (the REACT trial)
Source of recordUK Trials
ISRCTNISRCTN31931021
Date ISRCTN assigned16/11/2001
Local reference number(s)RG/98005
Public titleRescue angioplasty versus conservative treatment or repeat thrombolysis (the REACT trial)
Scientific title
AcronymREACT
Disease/condition/study domainMyocardial infarction
Study hypothesisNot provided at time of registration
Design/methodologyRandomised controlled trial
Research ethics reviewNot provided at time of registration
Countries of trialUnited Kingdom
Participants - inclusion criteria1. Patients with acute myocardial infarction presenting within 6 hours who have received aspirin and an accepted thrombolytic drug
2. Aged 21 - 85 years and able to give informed consent
3. Ability to undertake coronary intervention within 12 hours of onset of chest pain
4. All patients to have failed reperfusion 90 minutes from the start of thrombolysis
Participants - exclusion criteriaNot provided at time of registration
Patient information material
Anticipated start date01/12/1999
Anticipated end date01/03/2004
Status of trialStopped
Target number of participantsNot provided at time of registration
InterventionsPatients to be randomised to:
1. Rescue Percutaneous Transluminal Coronary Angioplasty (PTCA) - stent placement or platelet glycoprotein receptor blockers and the use of intra-aortic balloon pulsation will be guided by clinical need
2. Rescue thrombolysis with tissue Plasminogen Activator (tPA), reteplase, tenecteplase
3. Conservative treatment - intravenous (iv) heparin for 24 hours
Primary outcome measure(s)Not provided at time of registration
Secondary outcome measure(s)Not provided at time of registration
PublicationsResults in http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=PubMed&list_uids=16382062
Sources of fundingBritish Heart Foundation (UK) (ref: RG/98005)
Sponsor nameBritish Heart Foundation (UK)
Sponsor details14 Fitzhardinge Street
London
United Kingdom
W1H 6DH
Sponsor telephone+44 (0)20 7935 0185
Sponsor fax+44 (0)20 7486 5820
Sponsor emailresearch@bhf.org.uk
Sponsor websitehttp://www.bhf.org.uk/
Contact nameDr AH Gershlick
Contact detailsAcademic Dept of Cardiology
Clinical Sciences Wing
Glenfield General Hospital
Leicester
United Kingdom
LE3 9QP
Contact telephone+44 (0)116 256 3038
Contact fax+44 (0)116 2875792
Contact emailagershlick@aol.com
More informationFor more up-to-date information please go to the ISRCTN link below.
Link to record in ISRCTN RegisterISRCTN31931021
Date last extracted from ISRCTN register17/04/2008
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 Current Controlled Trials Ltd. Part of Springer Science+Business Media. | terms & conditions | privacy statement


BioMed Central